Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
about
Emerging Mechanisms of Aminoacyl-tRNA Synthetase Mutations in Recessive and Dominant Human Disease.Human aminoacyl-tRNA synthetases in diseases of the nervous system.Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.A single Danio rerio hars gene encodes both cytoplasmic and mitochondrial histidyl-tRNA synthetases.The role of tRNA synthetases in neurological and neuromuscular disorders.A recurrent WARS mutation is a novel cause of autosomal dominant distal hereditary motor neuropathy.
P2860
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@ast
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@en
type
label
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@ast
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@en
prefLabel
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@ast
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@en
P2860
P356
P1476
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease
@en
P2093
Laurie B Griffin
Nikos Malissovas
P2860
P304
P356
10.1093/HMG/DDW031
P577
2016-02-07T00:00:00Z